BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35168512)

  • 21. WITHDRAWN: Design and Evaluation of Floating Micro-Carriers for Effective Delivery of a Hydrophobic Drug.
    Hussain Z; Hongcai L; Ling Z; Nawaz MA; Naz AF; Yong W
    Curr Drug Deliv; 2022 May; ():. PubMed ID: 35578878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withdrawal Notice: Applications of Microbubbes as a Nano-carrier for cancer Theranostics.
    Chaudhary A; Setia A; Singh D; Bhattacharya S
    Pharm Nanotechnol; 2021 Sep; ():. PubMed ID: 34496738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Withdrawal Notice: Mortality, prevalence, and possible therapeutics to treat diabetic patients infected with nCOVID-19.
    Ashique S; Sandhu NK
    Curr Diabetes Rev; 2021 Feb; ():. PubMed ID: 33593262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Withdrawal Notice: Novel Pickering Emulsion Approach to Restrain Cancer Predicament.
    Singh SK; Baghel YS; Bhattacharya S
    Mini Rev Med Chem; 2020 Sep; ():. PubMed ID: 32875984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WITHDRAWN: Development, In Vitro and Ex-Vivo Assessment of CAP Liposomal Film for Dermal Delivery.
    Babu N; Beeravelli S; Murthy Kolapalli VR; Nimmathota M
    Recent Pat Nanotechnol; 2022 Feb; ():. PubMed ID: 35209831
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Withdrawal Notice: S.A.R.S Covid-19 A Medicinal Chemistry Approach.
    Bhardwaj G; Tonk RK; Garg H; Bhalla V
    Mini Rev Med Chem; 2021 Jan; ():. PubMed ID: 33573545
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Withdrawal Notice: Application of Nanomaterials in Development of Electrochemical Sensors and Drug Delivery Systems for Anticancer Drugs.
    Ghalkhani M; Kaya SI; Bakirhan NK; Ozkan Y; Ozkan SA
    Curr Drug Deliv; 2020 May; ():. PubMed ID: 32472999
    [TBL] [Abstract][Full Text] [Related]  

  • 28. WITHDRAWN: Obesity Paradox and Cardiovascular Diseases.
    Ganna I; Anna S
    Curr Cardiol Rev; 2022 May; ():. PubMed ID: 35570515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WITHDRAWN: Moderna’s COVID 19 Patent Under the Magnifying Glass.
    Storz U
    Recent Pat Biotechnol; 2022 Jun; ():. PubMed ID: 35713124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WITHDRAWN: Computational Chemistry in the Fight Against SARSCoV-2.
    Khan A; Wei DQ
    Comb Chem High Throughput Screen; 2022 Jan; ():. PubMed ID: 35021969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Withdrawal Notice: Therapeutic Targets Underlying the Evolution of Po-tential Anti-Diabetic Agents: A Comprehensive Review.
    Tiwari S; Kaur P; Gupta D; Chaudhury S; Chaudhary M; Chandra A; Sahu SK; Mittal A; Kumar S
    Curr Diabetes Rev; 2021 Dec; ():. PubMed ID: 34872480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Withdrawal Notice: Mucoadhesive Microspheres: An Emerging Trends in Therapy of Diabetes Mellitus.
    Singh D; Choudhary D
    Curr Diabetes Rev; 2020 Jul; ():. PubMed ID: 32674736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Withdrawal Notice: Design and Development of Key Chain Held Insulin injectable device.
    Manarvi IA; Matta NM
    Curr Diabetes Rev; 2020 Jul; ():. PubMed ID: 32619171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Withdrawal Notice: Fatal Outcomes from COVID-19 in Diabetes Patients and its Management: Impact of Diabetes and Other Comorbidities in COVID-19.
    Singh S; Bhatt P; Sharma SK; Kaur T
    Curr Diabetes Rev; 2021 Jun; ():. PubMed ID: 34077350
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Notice of Withdrawal.
    Curr Top Med Chem; 2019 Nov; ():. PubMed ID: 31724501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Notice of Withdrawal.
    Curr Top Med Chem; 2019 Nov; ():. PubMed ID: 31724499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Notice of Withdrawal.
    Curr Cancer Drug Targets; 2017 Jun; ():. PubMed ID: 28669348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Withdrawal Notice: Lead Optimization from Natural Ligands by In-Silico Approach for Discovering Potential Monoamine Oxidasesinhibitors (MAOIs).
    Dhiman P; Malik N; Khatkar A
    Curr Drug Metab; 2020 May; ():. PubMed ID: 32357811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Withdrawal Notice: A Novelistic Approach for Delivering of API through a Transvermillion Route: An updated review.
    Singh B; Madhav NVS
    Curr Drug Res Rev; 2021 Aug; ():. PubMed ID: 34391380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withdrawal Notice: Management of Right Atrial Thrombus. Where is the Evidence? : A Narrative Review.
    Sheikh O; Gulick D; Saenger E; Parmar R; Chilton R; Bailey S
    Curr Cardiol Rev; 2019 Oct; ():. PubMed ID: 31657680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.